Kazia Therapeutics Ltd ADR (KZIA) Financials

KZIA Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 14.9 million 21.9 million
June 30, 2024 14.4 million 21.1 million
Dec. 31, 2023 16.6 million 13.0 million
Sept. 30, 2023 18.1 million 10.3 million

KZIA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 ? ?
June 30, 2024 ? ?
Dec. 31, 2023 -4.3 million 297363
Sept. 30, 2023 -4.1 million 137814

KZIA Net Income

No data available :(

KZIA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 1.1 million - -
June 30, 2024 1.1 million - -
Dec. 31, 2023 2.4 million - -
Sept. 30, 2023 3.4 million - -

KZIA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 ?
June 30, 2024 ?
Dec. 31, 2023 16.3 million
Sept. 30, 2023 14.3 million

KZIA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - - - -
June 30, 2024 - - - -
Dec. 31, 2023 - 2.9 million 3.1 million -
Sept. 30, 2023 - 4.0 million 2.8 million -

KZIA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 - -
June 30, 2024 - -
Dec. 31, 2023 3 -
Sept. 30, 2023 356 -

KZIA

Price: $13.52

52 week price:
4.86
17.40

Earnings Per Share: -13.02 USD

P/E Ratio: -0.65

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 38900

Market Capitalization: 20.0 million

Links: